Pulmonary sarcoidosis
MONDO:0001708Sarcoidosis affecting the lung parenchyma. It is characterized by the presence of non-necrotizing granulomas in the lung tissues. It is manifested with dyspnea, cough, fever, night sweats, fatigue, and weight loss.
Also known as: lung sarcoidosis, sarcoidosis of lung
89 clinical trials for this condition and its sub-types, 20 tagged with Pulmonary sarcoidosis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Can a new infusion drug tame lung inflammation and cut steroid use?
Disease control OngoingThis trial is investigating whether an experimental drug called XTMAB-16 can safely control pulmonary sarcoidosis over the long term. The study includes people who have already completed a previous XTMAB-16 trial and are on a stable steroid dose. Researchers are monitoring side e…
Phase 2 • Sponsor: Xentria, Inc. • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Could antibiotics tame sarcoidosis? new study investigates
Disease control OngoingThis study looks at whether a combination of two antibiotics (azithromycin and doxycycline) can reduce bacteria linked to sarcoidosis and lower inflammation. About 40 adults with biopsy-confirmed sarcoidosis and active inflammation on a PET scan will receive the antibiotics or a …
Sponsor: St. Antonius Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New biopsy technique may improve sarcoidosis diagnosis
Diagnosis OngoingThis study will compare two ways to diagnose sarcoidosis, a disease that causes inflammation and lumps (granulomas) in the lungs. About 469 people with suspected stage I or II sarcoidosis will be randomly assigned to receive either a newer method called EBUS-guided cryobiopsy or …
Sponsor: China-Japan Friendship Hospital • Aim: Diagnosis
Last updated Aug 08, 2026 00:03 UTC
-
Study reveals: sticking to sarcoidosis meds may improve outcomes
Knowledge-focused OngoingThis study looks at how well people with sarcoidosis take their prescribed medicines and whether that affects their disease. Researchers will follow 150 adults in Maryland and D.C. for one year, tracking lung function, symptoms, and hospital visits. The goal is to find ways to he…
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC